Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Preprints
, 2024, Peanut oral immunotherapy plus omalizumab for 24 weeks safely induces tolerance at 48 weeks in allergic adults (The OPAL Study), http://dx.doi.org/10.22541/au.171724288.82777427/v1